HK1013998A1 - Carbapenems containing a carboxy substituted phenyl group processes for their preparation intermediates and use as antibiotics - Google Patents

Carbapenems containing a carboxy substituted phenyl group processes for their preparation intermediates and use as antibiotics

Info

Publication number
HK1013998A1
HK1013998A1 HK98115416A HK98115416A HK1013998A1 HK 1013998 A1 HK1013998 A1 HK 1013998A1 HK 98115416 A HK98115416 A HK 98115416A HK 98115416 A HK98115416 A HK 98115416A HK 1013998 A1 HK1013998 A1 HK 1013998A1
Authority
HK
Hong Kong
Prior art keywords
carbapenems
antibiotics
phenyl group
substituted phenyl
carboxy substituted
Prior art date
Application number
HK98115416A
Other languages
English (en)
Inventor
Michael John Betts
Gareth Morse Davies
Michael Lingard Swain
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of HK1013998A1 publication Critical patent/HK1013998A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK98115416A 1992-02-04 1998-12-24 Carbapenems containing a carboxy substituted phenyl group processes for their preparation intermediates and use as antibiotics HK1013998A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929202298A GB9202298D0 (en) 1992-02-04 1992-02-04 Antibiotic compounds
PCT/GB1993/000217 WO1993015078A1 (en) 1992-02-04 1993-02-02 Carbapenems containing a carboxy substituted phenyl group, processes for their preparation, intermediates and use as antibiotics

Publications (1)

Publication Number Publication Date
HK1013998A1 true HK1013998A1 (en) 1999-09-17

Family

ID=10709764

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98115416A HK1013998A1 (en) 1992-02-04 1998-12-24 Carbapenems containing a carboxy substituted phenyl group processes for their preparation intermediates and use as antibiotics

Country Status (35)

Country Link
US (7) US5478820A (zh)
EP (1) EP0579826B1 (zh)
JP (1) JP2730600B2 (zh)
KR (1) KR100200986B1 (zh)
CN (1) CN1036006C (zh)
AP (1) AP398A (zh)
AT (1) ATE173262T1 (zh)
AU (1) AU668133B2 (zh)
CA (1) CA2106370C (zh)
CZ (1) CZ286878B6 (zh)
DE (2) DE69322007T2 (zh)
DK (1) DK0579826T3 (zh)
ES (1) ES2123654T3 (zh)
FI (1) FI104074B1 (zh)
GB (2) GB9202298D0 (zh)
GE (1) GEP20022694B (zh)
HK (1) HK1013998A1 (zh)
HR (1) HRP930103B1 (zh)
HU (3) HU213675B (zh)
IL (1) IL104588A (zh)
LU (1) LU90970I2 (zh)
MY (1) MY111685A (zh)
NL (1) NL300104I2 (zh)
NO (2) NO304315B1 (zh)
NZ (2) NZ272038A (zh)
PL (3) PL174649B1 (zh)
RU (1) RU2117659C1 (zh)
SG (1) SG48817A1 (zh)
SI (1) SI9300056B (zh)
SK (1) SK280890B6 (zh)
TW (1) TW408124B (zh)
UA (1) UA44885C2 (zh)
WO (1) WO1993015078A1 (zh)
YU (1) YU48998B (zh)
ZA (1) ZA93453B (zh)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2106330A1 (en) * 1992-10-07 1994-04-08 Patrice J. Siret Antibiotic compounds
US5602118A (en) * 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
GB9515975D0 (en) 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
UA62920C2 (en) * 1996-05-28 2004-01-15 Merck & Co Inc Carbapeneme antibiotic, a composition and a method for the preparation
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation
AR008255A1 (es) * 1996-07-12 1999-12-29 Merck & Co Inc Procedimiento para sintetizar antibioticos de carbapenem
EP0923545A1 (en) 1996-08-17 1999-06-23 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
JP2001501948A (ja) * 1996-10-10 2001-02-13 メルク エンド カンパニー インコーポレーテッド カルバペネム側鎖中間体の合成法
US5877328A (en) * 1996-10-10 1999-03-02 Merck & Co., Inc. Process for synthesizing carbapenem side chain intermediates
JP2000508343A (ja) * 1996-10-28 2000-07-04 メルク エンド カンパニー インコーポレーテッド 安定化されたカルバペネム抗生物質組成物及びその製造方法
YU65899A (sh) * 1997-06-16 2001-05-28 Merck & Co. Inc. Stabilizovani karbapenem intermedijari i sintetska upotreba
US6180783B1 (en) 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
JP3378021B2 (ja) * 1997-07-10 2003-02-17 メルク エンド カンパニー インコーポレーテッド 結晶形態の抗菌性側鎖中間体
US5965747A (en) * 1997-07-10 1999-10-12 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
US5872250A (en) * 1997-07-30 1999-02-16 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics
ES2260900T3 (es) * 1998-03-02 2006-11-01 MERCK & CO., INC. Procedimiento para sintetizar antibioticos de carbapenem.
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
WO1999065921A1 (en) 1998-06-17 1999-12-23 Merck & Co., Inc. Process for the synthesis of carbapenem intermediates, and compounds produced
US6486150B2 (en) 1999-10-29 2002-11-26 Merck & Co., Inc. Process for formulation of antibiotic compounds
US6548492B1 (en) 1999-10-29 2003-04-15 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
GB9930317D0 (en) * 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930318D0 (en) * 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
AR035728A1 (es) * 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
AU2002331885B2 (en) * 2001-09-26 2007-07-26 Merck & Co., Inc. Crystalline forms of ertapenem sodium
MXPA04002797A (es) * 2001-09-26 2004-07-02 Merck & Co Inc Procedimiento para elaborar compuestos de carbapenemo.
EP1446009A2 (en) * 2001-11-08 2004-08-18 Merck & Co., Inc. Compounds useful in the treatment of anthrax
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
SI1511472T1 (sl) * 2002-05-29 2009-08-31 Merck & Co Inc Spojine uporabne pri zdravljenju antraksa in inhibiranju letalnega faktorja
EP1747550A2 (en) * 2004-05-07 2007-01-31 Infinium Labs, Inc. Multi-position multi-level user interface system
CA2566191A1 (en) * 2004-05-11 2005-12-15 Merck & Co., Inc. Process for making n-sulfonated-amino acid derivatives
US20100003276A1 (en) * 2004-12-07 2010-01-07 Hermes Jeffery D Methods for treating anthrax and inhibiting lethal factor
CN100344613C (zh) * 2005-10-20 2007-10-24 上海交通大学 (2s,4s)－1－(4－硝基苄氧羰基)－2－[(3－烯丙氧羰基)－苯基氨基甲酰基]－吡咯烷－4－基硫醇的制备方法
ES2373461T3 (es) * 2005-12-07 2012-02-03 Basilea Pharmaceutica Ag Antibióticos útiles de monobactama.
AU2012233003B2 (en) * 2005-12-07 2014-12-18 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
US8293894B2 (en) * 2006-11-20 2012-10-23 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
CN101357916B (zh) * 2007-06-22 2010-12-15 山东轩竹医药科技有限公司 含有二氢咪唑甲酰胺基的培南化合物
CN101367807B (zh) * 2007-06-28 2011-01-12 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰胺基吡啶取代的培南衍生物
CN101367815B (zh) * 2007-06-28 2012-07-04 山东轩竹医药科技有限公司 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物
CN101362760B (zh) * 2007-08-07 2010-12-15 山东轩竹医药科技有限公司 1β-甲基碳代青霉烯化合物
CN101362761B (zh) * 2007-08-12 2011-05-18 山东轩竹医药科技有限公司 含有巯基哌啶的碳代青霉烯抗生素
CN101412720B (zh) * 2007-08-27 2011-05-18 山东轩竹医药科技有限公司 含有巯基氮杂环乙烯基的碳青霉烯化合物
CN101376641B (zh) * 2007-08-28 2010-12-08 上海医药工业研究院 碳青霉烯类青霉素厄他培南的中间体及其制备方法和应用
EP2505190A1 (en) 2008-06-11 2012-10-03 Ranbaxy Laboratories Limited Polymorphic forms of ertapenem monosodium salt and process for it's preparation
AU2009277936B2 (en) * 2008-07-30 2014-11-27 Sun Pharmaceutical Industries Limited Process for the preparation of carbapenem compounds
CA2737879C (en) * 2008-09-18 2014-07-08 Manu Chaudhary Single unit carbapenem aminoglycoside formulations
EP2426131B1 (en) 2009-04-30 2016-08-17 CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. Intermediates of carbapenem, compositions containing them and preparation methods thereof
WO2011048583A1 (en) 2009-10-23 2011-04-28 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
US8729260B2 (en) 2010-05-19 2014-05-20 Savior Lifetec Corporation Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem
CN102558182B (zh) 2010-12-31 2015-02-11 石药集团中奇制药技术（石家庄）有限公司 一种厄他培南钠晶型及其制备方法
US8691803B2 (en) 2011-01-24 2014-04-08 Savior Lifetec Corporation Process for the preparation of antibiotic compounds
WO2013121279A2 (en) * 2012-02-14 2013-08-22 Aurobindo Pharma Limited Process to prepare ertapenem
AU2013328585A1 (en) * 2012-10-12 2015-04-09 Sandoz Ag Preparation of ertapenem intermediates
BR112015023621A8 (pt) * 2013-03-15 2018-01-23 Kala Pharmaceuticals Inc derivados de meropenem e suas utilizações
IN2013MU03862A (zh) 2013-12-11 2015-07-31 Unimark Remedies Ltd
JP7213173B2 (ja) 2016-03-16 2023-01-26 オーキッド ファーマ リミテッド カルバペネム化合物
CN106565579A (zh) * 2016-06-26 2017-04-19 宁夏海诚电化信息科技有限公司 一种尔它培南侧链生产工艺
CN110698480B (zh) * 2018-07-09 2023-09-08 武汉启瑞药业有限公司 一种厄他培南中间体的合成及纯化方法
TWI807157B (zh) * 2019-01-23 2023-07-01 醣解生醫股份有限公司 β-內醯胺類化合物或其鹽於長效預防或治療葡萄糖代謝失調之用途

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218462A (en) * 1978-10-24 1980-08-19 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1-substituted-1-carbade-thiapen-2-em-3-carboxylic acids
US4208422A (en) * 1978-10-24 1980-06-17 Merck & Co., Inc. 1-Substituted-pen-2-em-3-carboxylic acids
US4206219A (en) * 1978-10-24 1980-06-03 Merck & Co., Inc. 6- and 1-Substituted-1-carbadethiapen-2-em-3-carboxylic acid
US4232036A (en) * 1978-10-24 1980-11-04 Merck & Co., Inc. 6-, 1- and 2-Substituted-1-carbadethiapen-2-em-3-carboxylic acids
EP0017992A1 (en) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids, processes for preparing them, antibiotic pharmaceutical compositions containing same and process for preparing intermediates
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
CA1281720C (en) * 1984-11-08 1991-03-19 Makoto Sunagawa Carbapenem compounds and production thereof
FI81576C (fi) * 1984-12-25 1990-11-12 Sankyo Co Foerfarande foer framstaellning av derivat av 6-(1-hydroxietyl)-2-(1,2-disubstituerade-4-pyrrolidinyltio)-2- karbapenem-3-karboxylsyra, vilka aer anvaendbara som laekemedel.
ES2051700T3 (es) * 1986-03-27 1994-07-01 Sumitomo Pharma Un proceso para la preparacion de un compuesto beta-lactama.
US4974544A (en) * 1986-10-07 1990-12-04 Ricoh Company, Co. Vapor deposition apparatus
US5194624A (en) * 1988-05-23 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Intermediates for the preparation of compounds of antimicrobial activity
US4963544A (en) * 1988-05-23 1990-10-16 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
GB8923844D0 (en) * 1989-10-23 1989-12-13 Fujisawa Pharmaceutical Co Carbapenem compounds
FI96863C (fi) * 1990-02-23 1996-09-10 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten /2-(1-homopiperatsiinikarbonyyli)pyrrolidin-4-yylitio/-6-(1-hydroksietyyli)-1-karbapen-2-eemi-3-karboksylaattisuolojen valmistamiseksi
US5554606A (en) * 1990-03-12 1996-09-10 Zeneca Limited Antibiotic compounds
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
GB9107342D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
GB9107341D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
FI101226B1 (fi) * 1991-06-04 1998-05-15 Sankyo Co Menetelmä lääkeaineena käyttökelpoisten 2-[2-(karbonyyli)pyrrolidin-4-yylitio]-6-(1-hydroksietyyli)-1-metyylikarbapen-2-eemi-3-karboksyylihappojohdannaisten valmistamiseksi
ZA929008B (en) * 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
GB9304156D0 (en) * 1992-03-26 1993-04-21 Zeneca Ltd Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds
CA2099811A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2099817A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2099818A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2106141A1 (en) * 1992-09-28 1994-03-29 Michael J. Betts Antibiotic compounds

Also Published As

Publication number Publication date
YU5493A (sh) 1996-05-20
PL174649B1 (pl) 1998-08-31
FI930474A (fi) 1993-08-05
WO1993015078A1 (en) 1993-08-05
RU2117659C1 (ru) 1998-08-20
HU9302777D0 (en) 1993-12-28
DE10299041I1 (de) 2003-02-20
NO933530D0 (no) 1993-10-01
AP9300480A0 (en) 1993-01-31
US5652233A (en) 1997-07-29
US5478820A (en) 1995-12-26
NO933530L (no) 1993-10-04
EP0579826A1 (en) 1994-01-26
JP2730600B2 (ja) 1998-03-25
US20030144264A1 (en) 2003-07-31
JPH06506704A (ja) 1994-07-28
PL174936B1 (pl) 1998-10-30
DE10299041I2 (de) 2003-06-12
FI104074B (fi) 1999-11-15
HUT64764A (en) 1994-02-28
ES2123654T3 (es) 1999-01-16
HU211840A9 (en) 1995-12-28
HU213675B (en) 1997-09-29
LU90970I2 (fr) 2002-12-09
HRP930103B1 (en) 1999-12-31
DK0579826T3 (da) 1999-07-26
ZA93453B (en) 1993-08-05
US7342005B2 (en) 2008-03-11
UA44885C2 (uk) 2002-03-15
HUT66514A (en) 1994-12-28
CA2106370C (en) 2003-11-25
NZ246917A (en) 1995-09-26
CN1036006C (zh) 1997-10-01
HRP930103A2 (en) 1994-12-31
DE69322007T2 (de) 1999-04-01
KR100200986B1 (ko) 1999-06-15
SG48817A1 (en) 1998-05-18
AU668133B2 (en) 1996-04-26
SK280890B6 (sk) 2000-09-12
AU3457493A (en) 1993-09-01
YU48998B (sh) 2003-04-30
NL300104I2 (nl) 2003-02-03
FI930474A0 (fi) 1993-02-03
US20050209212A1 (en) 2005-09-22
GB9202298D0 (en) 1992-03-18
GEP20022694B (en) 2002-05-10
MY111685A (en) 2000-11-30
PL174601B1 (pl) 1998-08-31
CA2106370A1 (en) 1993-08-05
TW408124B (en) 2000-10-11
DE69322007D1 (de) 1998-12-17
AP398A (en) 1995-08-29
ATE173262T1 (de) 1998-11-15
CN1079224A (zh) 1993-12-08
SK106393A3 (en) 1994-04-06
IL104588A0 (en) 1993-06-10
CZ286878B6 (en) 2000-07-12
NO304315B1 (no) 1998-11-30
US6187804B1 (en) 2001-02-13
SI9300056B (sl) 2000-02-29
SI9300056A (en) 1993-09-30
NO2002010I2 (no) 2005-03-11
CZ206793A3 (en) 1994-04-13
US7041836B2 (en) 2006-05-09
EP0579826B1 (en) 1998-11-11
US5856321A (en) 1999-01-05
NZ272038A (en) 1997-07-27
US6521612B2 (en) 2003-02-18
GB9300456D0 (en) 1993-03-03
US20020042408A1 (en) 2002-04-11
NL300104I1 (nl) 2002-12-02
IL104588A (en) 1999-03-12
FI104074B1 (fi) 1999-11-15
NO2002010I1 (no) 2002-10-09

Similar Documents

Publication Publication Date Title
HK1013998A1 (en) Carbapenems containing a carboxy substituted phenyl group processes for their preparation intermediates and use as antibiotics
AU4084193A (en) Toothbrush
AU5151293A (en) Oral hygiene composition
EP0717633A4 (en) GROWTH DIFFERENTIATION FACTOR-7
AU4466793A (en) Spray can
SG77541A1 (en) Novel 2-thiosubstituted carbapenems
AU5067593A (en) Novel cleaning compositions
ZW3493A1 (en) Antibiotic compounds
AU3344093A (en) Brush
AU4978693A (en) Cleaning head
AU2441692A (en) Power-driven rotary toothbrush
AU5426994A (en) Toothbrush
AU3720793A (en) Toothpaste composition
AU3048492A (en) New compounds
AU3200493A (en) Ganglioside-GM3-fortified nutrient composition
AU4680393A (en) Disposable toothbrush
HK1008336A1 (en) Preparation of beta-methyl carbapenem intermediates
AU5008993A (en) Cleaning composition
AU4746593A (en) BU-4803T antibiotics
AU645734B3 (en) A sponge for cleaning surfaces
AU3765393A (en) Bubblers
AU630326B3 (en) Double-threaded tooth pick
AU638924B3 (en) Inking head
GB8807793D0 (en) Precursors for group ii fluoride & use thereof
AU2003200421A1 (en) Enantiomerically pure beta-D-dioxolane-nucleosides

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20130201